Functional genomics of staphylococcus aureus

Briefings in Functional Genomics

Volumn 12, Issue 4, 2013, Pages 305-315

  Chua, Kyra Y L ^a   Stinear, Timothy P ^a   Howden, Benjamin P ^b  

^a University of Melbourne ^*

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antibiotic resistance; Genome sequencing; Genomics; Pathogenesis; Staphylococcus aureus

Indexed keywords

COMPLEMENTARY RNA; RIBONUCLEASE III; TRANSCRIPTOME;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; DNA METHYLATION; DNA MICROARRAY; DNA MODIFICATION; DNA SEQUENCE; ELECTRIC FIELD; FUNCTIONAL GENOMICS; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENETIC MANIPULATION; GENOMIC ISLAND; HIGH THROUGHPUT SEQUENCING; HORIZONTAL GENE TRANSFER; INNATE IMMUNITY; KNOCKOUT GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PENICILLIN RESISTANCE; RNA SEQUENCE; TRANSPOSON;

ANTIBIOTIC RESISTANCE; GENOME SEQUENCING; GENOMICS; PATHOGENESIS; STAPHYLOCOCCUS AUREUS;

DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; GENOMICS; STAPHYLOCOCCUS AUREUS;

EID: 84882978875     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elt006     Document Type: Article

References (99)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32.
2. Jevons MP. ''Celbenin''-resistant Staphylococci. Br Med J 1961;1:124-5.
3. Barber M. Methicillin-resistant Staphylococci. J Clin Pathol 1961;14:385-93.
4. Chambers HF, Deleo F. Waves of resistance: Staphylococcus aureus in the antibiotic era. NatRevMicrobiol 2009;7:629-41.
5. Holmes NE, Johnson PD, Howden BP. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin- intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. J Clin Microbiol 2012;50:2548-52.
6. Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355: 653-65.
7. Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin InfectDis 2004;39:1010-5.
8. Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304: 641-8.
9. David MZ, Daum RS. Community-associated methicillinresistant Staphylococcusaureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010;23:616-87.
10. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. JHosp Infect 1993;25:97-108.
11. Centers for Disease Control and Prevention. Four Pediatric Deaths from Community-Acquired Methicillin-Resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999;48: 707-10.
12. Kim HK, Thammavongsa V, Schneewind O, et al. Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr OpinMicrobiol 2012;15:92-9.
13. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001;357:1225-40.
14. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359:1819-27.
15. Hienz SA, Schennings T, Heimdahl A, et al. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J InfectDis 1996;174:83-8.
16. Gillaspy AF, Worrell V, Orvis J, et al. The Staphylococcus aureus NCTC 8325 Genome. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds). Gram Positive Pathogens. 2nd edn. Washington D.C.: ASM Press, 2006:381-412.
17. Highlander SK, Hulten KG, Qin X, et al. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMCMicrobiol 2007;7:99.
18. Kennedy AD, Otto M, Braughton KR, et al. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad SciUSA 2008;105:1327-32.
19. Baba T, Bae T, Schneewind O, et al. Genome sequence of Staphylococcusaureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 2008;190: 300-10.
20. Gill SR, Fouts DE, Archer GL, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 2005;187:2426-38.
21. Holden MT, Lindsay JA, Corton C, et al. Genome sequence of a recently emerged, highly transmissible, multiantibiotic- and antiseptic-resistant variant of methicillinresistant Staphylococcus aureus, sequence type 239 (TW). J Bacteriol 2010;192:888-92.
22. Howden BP, Seemann T, Harrison PF, et al. Complete genome sequence of Staphylococcus aureus strain JKD6008, an ST239 clone of methicillin-resistant Staphylococcus aureus with intermediate-level vancomycin resistance. J Bacteriol 2010;192:5848-9.
23. Li M, Du X, Villaruz AE, et al. MRSA epidemic linked to a quickly spreading colonization and virulence determinant. NatMed 2012;18:816-9.
24. Li Y, Cao B, Zhang Y, et al. Complete genome sequence of Staphylococcusaureus T0131, an ST239-MRSA-SCCmec type III clone isolated in China. J Bacteriol 2011;193:3411-2.
25. Harris SR, Feil EJ, Holden MT, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010;327:469-74.
26. Sass P, Berscheid A, Jansen A, et al. Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycinresistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics. J Bacteriol 2012;194:2107-8.
27. Neoh HM, Cui L, Yuzawa H, et al. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycinintermediate resistance to vancomycin-intermediate resistance. Antimicrob Agents Chemother 2008;52:45-53.
28. Mwangi MM, Wu SW, Zhou Y, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci US A 2007; 104:9451-6.
29. Lowder BV, Guinane CM, Ben Zakour NL, et al. Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proc Natl Acad Sci U S A 2009;106:19545-50.
30. Nubel U, Dordel J, Kurt K, et al. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog 2010;6:e1000855.
31. Holden MT, Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad SciUSA 2004;101:9786-91.
32. Herron-Olson L, Fitzgerald JR, Musser JM, et al. Molecular correlates of host specialization in Staphylococcus aureus. PLoS One 2007;2:e1120.
33. Schijffelen MJ, Boel CH, van Strijp JA, et al. Whole genome analysis of a livestock-associated methicillin-resistant Staphylococcus aureus ST398 isolate from a case of human endocarditis. BMCGenomics 2010;11:376.
34. Golding GR, Bryden L, Levett PN, et al. Whole-genome sequence of livestock-associated ST398 methicillin-resistant Staphylococcus aureus isolated from humans in Canada. J Bacteriol 2012;194:6627-8.
35. Chua K, Seemann T, Harrison PF, et al. Complete genome sequence of Staphylococcus aureus strain JKD6159, a unique Australian clone of ST93-IV community methicillin-resistant Staphylococcus aureus. J Bacteriol 2010; 192:5556-7.
36. Holt DC, Holden MT, Tong SY, et al. A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol 2011;3:881-95.
37. Stegger M, Price LB, Larsen AR, et al. Genome sequence of Staphylococcus aureus strain 11819-97, an ST80-IV European community-acquired methicillin-resistant isolate. J Bacteriol 2012;194:1625-6.
38. Huang TW, Chen FJ, Miu WC, et al. Complete genome sequence of Staphylococcus aureus M013, a pvl-positive, ST59-SCCmec type V strain isolated in Taiwan. J Bacteriol 2012;194:1256-7.
39. Guinane CM, Ben Zakour NL, Tormo-Mas MA, et al. Evolutionary genomics of Staphylococcus aureus reveals insights into the origin and molecular basis of ruminant host adaptation. Genome Biol Evol 2010;2:454-66.
40. Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome?. Trends Microbiol 2004;12:378-85.
41. Lindsay JA, Holden MT. Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics 2006;6: 186-201.
42. Li M, Cheung GY, Hu J, et al. Comparative analysis of virulence and toxin expression of global communityassociated methicillin-resistant Staphylococcus aureus strains. J InfectDis 2010;202:1866-76.
43. Matsuhashi M, Song MD, Ishino F, et al. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol 1986;167:975-80.
44. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000;44:1549-55.
45. Queck SY, Khan BA, Wang R, et al. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 2009;5: e1000533.
46. Chatterjee SS, Chen L, Joo HS, et al. Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus. PLoS One 2011;6:e28781.
47. Kaito C, Saito Y, Nagano G, et al. Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog 2011;7:e1001267.
48. McAdam PR, Templeton KE, Edwards GF, et al. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. ProcNatl Acad SciUSA 2012;109:9107-12.
49. Fitzgerald JR, Sturdevant DE, Mackie SM, et al. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. ProcNatlAcad SciUSA 2001;98: 8821-6.
50. van Loo I, Huijsdens X, Tiemersma E, et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 2007;13:1834-9.
51. Price LB, Stegger M, Hasman H, et al. Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. MBio 2012;3: e00305-00311.
52. Uhlemann AC, Porcella SF, Trivedi S, et al. Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. MBio 2012;3:e00027-00012.
53. Young BC, Golubchik T, Batty EM, et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. ProcNatl Acad SciUSA 2012;109:4550-5.
54. Dunman PM, Murphy E, Haney S, et al. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 2001;183: 7341-53.
55. Said-Salim B, Dunman PM, McAleese FM, et al. Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol 2003;185:610-9.
56. BischoffM, Dunman P, Kormanec J, et al. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J Bacteriol 2004;186:4085-99.
57. Howden BP, Smith DJ, Mansell A, et al. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin- resistant Staphylococcus aureus bacteraemia. BMCMicrobiol 2008;8:39.
58. Howden BP, McEvoy CR, Allen DL, et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog 2011;7:e1002359.
59. Delaune A, Dubrac S, Blanchet C, et al. The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect Immun 2012;80:3438-53.
60. Beaume M, Hernandez D, Farinelli L, et al. Cartography of methicillin-resistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditions. PLoS One 2010;5:e10725.
61. Lioliou E, Sharma CM, Caldelari I, et al. Global regulatory functions of the Staphylococcus aureus endoribonuclease III in gene expression. PLoS Genet 2012;8:e1002782.
62. Kraemer GR, Iandolo JJ. High-frequency transformation of Staphylococcus aureus by electroporation. CurrMicrobiol 1990; 21:373-6.
63. Schenk S, Laddaga RA. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett 1992;73: 133-8.
64. McNamara PJ. Genetic manipulation of Staphylococcus aureus. In: Lindsay JA (ed). Staphylococcus:MolecularGenetics. Norfolk, UK: Caister Academic Press, 2008:89-130.
65. Monk IR, Shah IM, Xu M, et al. Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. MBio 2012;3:e00277-00211.
66. Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 2006;55: 58-63.
67. DeLeo FR, Kennedy AD, Chen L, et al. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A 2011;108:18091-6.
68. Bubeck Wardenburg J, Bae T, Otto M, et al. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007;13: 1405-6.
69. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J InfectDis 2010;202:1050-8.
70. Recsei P, Kreiswirth B, O'Reilly M, et al. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol Gen Genet 1986;202:58-61.
71. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48:1429-49.
72. Wright JS, 3rd, Jin R, Novick RP. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci USA 2005;102:1691-6.
73. Howden BP, Stinear TP, Allen DL, et al. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 2008;52:3755-62.
74. Cameron DR, Ward DV, Kostoulias X, et al. Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis 2012;205:1677-87.
75. Gardete S, Kim C, Hartmann BM, et al. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog 2012;8:e1002505.
76. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of communityacquired meticillin-resistant Staphylococcus aureus. Lancet 2006;367:731-9.
77. Goering RV, McDougal LK, Fosheim GE, et al. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol 2007;45:1981-4.
78. Diep BA, Stone GG, Basuino L, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J InfectDis 2008;197:1523-30.
79. Montgomery CP, Boyle-Vavra S, Daum RS. The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community- associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect Immun 2009;77:2650-6.
80. Chua KY, Seemann T, Harrison PF, et al. The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One 2011;6:e25887.
81. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;315:1130-3.
82. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in communityassociated methicillin-resistant Staphylococcus aureus disease?. J InfectDis 2006;194:1761-70.
83. Loffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010;6:e1000715.
84. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad SciUSA 2010;107:5587-92.
85. Kobayashi SD, Malachowa N, Whitney AR, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011;204:937-41.
86. Lipinska U, Hermans K, Meulemans L, et al. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS One 2011;6:e22864.
87. Yao J, Zhong J, Fang Y, et al. Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll. LtrB group II intron splicing. RNA 2006;12:1271-81.
88. Corvaglia AR, Francois P, Hernandez D, et al. A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains. ProcNatl Acad SciUSA 2010;107:11954-8.
89. Bae T, Banger AK, Wallace A, et al. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. ProcNatlAcadSciUSA 2004;101:12312-7.
90. Mazurkiewicz P, Tang CM, Boone C, et al. Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet 2006;7:929-39.
91. Koser CU, Ellington MJ, Cartwright EJ, et al. Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog 2012;8: e1002824.
92. Beaume M, Hernandez D, Francois P, et al. New approaches for functional genomic studies in staphylococci. IntJMedMicrobiol 2010;300:88-97.
93. Monk IR, Foster TJ. Genetic manipulation of Staphylococci-breaking through the barrier. Front Cell InfectMicrobiol 2012;2:49.
94. Waldron DE, Lindsay JA. Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol 2006;188: 5578-85.
95. Murray NE. Type I restriction systems: sophisticated molecular machines (a legacy of Bertani and Weigle). Microbiol Mol Biol Rev 2000;64:412-34.
96. Kreiswirth BN, Lofdahl S, Betley MJ, et al. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 1983;305:709-12.
97. Lee JC. Electrotransformation of Staphylococci. Methods Mol Biol 1995;47:209-16.
98. Xu SY, Corvaglia AR, Chan SH, et al. A type IV modification-dependent restriction enzyme SauUSI from Staphylococcus aureus subsp. aureus USA300. Nucleic Acids Res 2011;39:5597-610.
99. Priest NK, Rudkin JK, Feil EJ, et al. From genotype to phenotype: can systems biology be used to predict Staphylococcus aureus virulence? Nat Rev Microbiol 2012;10: 791-7.